AYURFAYURFOTC

Overview Intelligence Charts News Fundamentals

Latest News

globenewswire.com

AYURCANN REPORTS Q1 2026 SALES OF $14,638,697

Toronto, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce its financial and operational results for the three months ended September 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of unaudited condensed interim consolidated financial statements for the three months ended September 30, 2025 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca .

globenewswire.com

AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE

Toronto, Ontario, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR ; OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the year ended June 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated audited financial statements for the years ended June 30, 2025 and 2024 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca .

globenewswire.com

AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q2 2025 OF $13,363,509

Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce record-breaking financial results for the three months ended December 31, 2024, the highlights of which are included in this news release. As a leading player in the rapidly growing cannabis industry, Ayurcann continues to demonstrate exceptional growth and operational excellence, positioning itself for long-term success. All figures are reported in Canadian dollars. The Company's full set of consolidated financial statements for the three months ended December 31, 2024 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca .

globenewswire.com

AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q1 2025 OF $14,760,268 AND PROVIDES CORPORATE UPDATE

Toronto, Ontario, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the three months ended September 30, 2024, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated financial statements for the three months ended September 30, 2024 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.

globenewswire.com

AYURCANN TERMINATES BUSINESS COMBINATION

Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announces that, further to its press releases dated June 27, 2024 (the “June 27 Release”) and November 20, 2024, it has sent a letter to Arogo Capital Acquisition Corporation (“Arogo”) terminating the Business Combination in accordance with Section 10.1(c) of the Business Combination Agreement as a result of, among other things, Arogo's failure to perform the covenants set forth in Sections 8.11 (Stock Exchange Listing) and 8.22 (Public Filings) of the Business Combination Agreement. As a result of such termination, and in accordance with Section 10.2(c) of the Business Combination Agreement, Arogo is to pay the Company a fee in the amount of $250,000. Ayurcann disputes any payment demand from Arogo in connection with the termination. Capitalized terms not otherwise defined herein have the meanings attributed to them in the June 27 Release.

globenewswire.com

AYURCANN REPORTS FISCAL YEAR 2024 RECORD SALES OF $45,265,235 IN GROSS REVENUE, FEATURING ANOTHER 100% YEAR-OVER-YEAR INCREASE

Toronto, Ontario, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the year ended June 30, 2024, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated audited financial statements for the years ended June 30, 2024 and 2023 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.

globenewswire.com

Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.

Ayurcann is an award-winning Canadian cannabis extraction company that specializes in the processing and manufacturing of cannabis 2.0 and 3.0 products:

globenewswire.com

AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE

Toronto, Ontario, May 27, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and nine months ended March 31, 2024, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated financial statements for the three and nine months ended March 31, 2024 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.

globenewswire.com

AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE

Toronto, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various derivative cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and six months ended December 31, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated financial statements for the three and six months ended December 31, 2023 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.

globenewswire.com

Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs

Pickering, Ontario, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is please to announce the following corporate updates.

globenewswire.com

AYURCANN ANNOUNCES AGSM RESULTS

Toronto, Ontario, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company, specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to provide the following corporate updates.

globenewswire.com

AYURCANN REPORTS RECORD SALES IN Q1 2024 FEATURING A 249% INCREASE IN GROSS REVENUE

Toronto, Ontario, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various derivative cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three-months ended September 30, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated financial statements for the three-months ended September 30, 2023 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.

globenewswire.com

AYURCANN REPORTS 2023 FINANCIAL RESULTS FEATURING $22,371,604 IN GROSS REVENUE

Toronto, Ontario, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to announce its financial and operational results for the year ended June 30, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated audited financial statements for the years ended June 30, 2023 and 2022 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.

globenewswire.com

AYURCANN HOLDINGS CORP. PROVIDES CORPORATE UPDATE, AND GROWTH STRATEGY

Toronto, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis company specializing in the processing and manufacturing of cannabis 2.0 and 3.0 products in the recreational market, is pleased to provide a corporate update to its operations.

proactiveinvestors.com

Ayurcann Holdings enters agreement to acquire 100% of Joints and Hustle & Shake for $5.5M

Ayurcann Holdings Corp. (CSE:AYUR, OTCQB:AYURF) said it has entered into an agreement to acquire 100% of Joints and Hustle & Shake Inc. for $5,500,000.

proactiveinvestors.com

Ayurcann Holdings sees fiscal 3Q revenue rise to $2.8M as it gains more traction in the market

Ayurcann Holdings Corp. (CSE:AYUR, OTCQB:AYURF), a cannabis extraction company, said revenue in the third quarter of its fiscal year 2022 jumped nearly 7.7% year-over-year as it gained more traction in the market. For its fiscal 3Q ended March 31, 2022, the rapidly growing Toronto-based company reported net revenue of $2.8 million, compared to $2.6 million in the 3Q in fiscal year 2021.

proactiveinvestors.com

Ayurcann Holdings says it has received its flower sales license amendment from Health Canada effective April 19, 2022

Ayurcann Holdings Corp announced that it has received its flower sales license amendment from Health Canada effective April 19, 2022. The company said the flower sales license will allow it to sell dried cannabis flower products in Canada through authorized distributors and retailers.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance